Gateway Pharmacy and Sarhaddi Pharmaceutical Inc. are aware of fraudulent emails and websites falsely offering employment opportunities in our name.
We never request payment from applicants. If you receive suspicious communications claiming to represent our company, please contact us directly to verify authenticity.
GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds
In a new observational study, patients with migraine given a daily dose of liraglutide, a popular GLP-1 receptor agonist, reported significantly fewer headache days and an improved quality of life.
El servicio de noticias de salud es un servicio para los usuarios de la página web de Gateway Pharmacy gracias a HealthDay. Gateway Pharmacy ni sus empleados, agentes, o contratistas, revisan, controlan, o toman responsabilidad por el contenido de los artículos. Por favor busque consejo médico directamente de un farmacéutico o de su médico principal.